|
2022
|
Invention
|
Pyrimidine-fused ring compound with dna-pk inhibition activity and use thereof. The present inven... |
|
2021
|
Invention
|
Preparation method for edoxaban tosylate or hydrate thereof. The present invention relates to a p... |
|
|
Invention
|
Method for preparing compound as pi3k inhibitor and intermediate compound for preparing same. The... |
|
|
Invention
|
Novel pharmaceutical formulation having improved stability comprising amorphous empagliflozin. Th... |
|
|
Invention
|
Method for producing compound as pi3k inhibitor, and intermediate compound for production thereof... |
|
|
Invention
|
Novel pharmaceutical formulation with improved stability containing taxane, pharmaceutically acce... |
|
|
Invention
|
Composition comprising pi3 kinase inhibitor and btk inhibitor. The present invention provides a c... |
|
|
Invention
|
Hybrid compound and preparation method therefor. Disclosed in the present invention is a hybrid c... |
|
2020
|
Invention
|
Pyrido-pyrimidin derivatives and pharmaceutical composition, for use in preventing or treating pi... |
|
|
Invention
|
Amorphous pi3k inhibitor and pharmaceutical composition comprising same.
The present invention r... |
|
|
Invention
|
Crystal polymorphism of pi3k inhibitor and method for preparing same.
The present invention rela... |
|
|
Invention
|
Crystal polymorphism of pi3k inhibitor and method for preparing same. The present invention relat... |
|
|
Invention
|
Amorphous pi3k inhibitor and pharmaceutical composition comprising same. The present invention re... |
|
2019
|
Invention
|
Tablet and method of preparing same. The present invention relates to a tablet and a method for p... |
|
|
Invention
|
Bilayer tablet and preparation method therefor. In a bilayer tablet and a preparation method ther... |
|
|
Invention
|
Pharmaceutical formulation comprising edoxaban and preparation method therefor. The present inven... |
|
|
Invention
|
Pyrimidinone derivative compound and use thereof. The present invention provides a pyrimidinone d... |
|
|
Invention
|
Pharmaceutical preparation. The present invention provides a preparation containing fimasartan, a... |
|
|
Invention
|
Pharmaceutical composition. The present invention relates to a pharmaceutical composition compris... |
|
|
Invention
|
Pharmaceutical preparation. Provided is a preparation comprising fimasartan, amlodipine, and rosu... |
|
|
Invention
|
Pharmaceutical composition comprising pi3 kinase inhibitor and cytotoxic anti-cancer agent for pr... |
|
|
Invention
|
Pharmaceutical composition comprising pi3 kinase inhibitor and immune checkpoint inhibitor for p... |
|
2018
|
Invention
|
Composition comprising pi3 kinase inhibitor and bcl-2 inhibitor. The present invention relates to... |
|
|
Invention
|
Pharmaceutical composition comprising tofacitinib. The present invention relates to a pharmaceuti... |
|
|
Invention
|
Pharmaceutical composition comprising fimasartan. The present invention relates to a pharmaceutic... |
|
|
Invention
|
Solid dispersion comprising fimasartan. The present invention relates to a solid dispersion compr... |
|
|
Invention
|
Microneedle percutaneous patch containing donepezil. The present invention relates to a compositi... |
|
2017
|
G/S
|
Pharmaceuticals, namely, cardiovascular pharmaceuticals; drugs for medical purposes, namely, card... |
|
2016
|
G/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cardiovascu... |
|
|
Invention
|
Novel salt of fimasartan. The present invention provides: a novel salt of Fimasartan having excel... |
|
|
Invention
|
Pharmaceutical composition for preventing or treating diabetic nephropathy. A pharmaceutical comp... |
|
|
Invention
|
Tablet and method of preparing the same. Disclosed is a method for preparing a tablet. The method... |
|
2015
|
G/S
|
Pharmaceuticals, namely, pharmaceutical preparations for the treatment of cardiovascular diseases... |
|
|
Invention
|
Preparation, and manufacturing method therefor. A preparation containing erlotinib or a pharmaceu... |
|
2014
|
Invention
|
Pharmaceutical composition for preventing or treating ischemic brain disorders, containing fimasa... |
|
|
Invention
|
High-load imatinib tablet. The present invention provides a high-load imatinib tablet which, base... |
|
|
Invention
|
Pharmaceutical combination drug. Provided is a pharmaceutical combination preparation including f... |
|
|
Invention
|
Pharmaceutical combination drug. The present invention relates to a pharmaceutical combination dr... |
|
|
Invention
|
Composition for preventing or treating cancer. The present invention relates to a composition for... |
|
2013
|
Invention
|
Composition for preventing or treating inflammation. The present invention relates to a compositi... |
|
|
Invention
|
Monohydrate crystal of fimasartan potassium salt, method for preparing same, and pharmacological ... |
|
|
Invention
|
Novel compound, method for preparing same and pharmaceutical composition comprising same. The pre... |
|
|
Invention
|
Pharmaceutical composition for preventing, alleviating, or treating heart failure, and complex fo... |
|
|
Invention
|
Pharmaceutical composition containing fimasartan and hydrochlorothiazide. The present invention p... |
|
2012
|
Invention
|
Compound having angiogenesis inhibitory activity, method for preparing same, and pharmaceutical c... |
|
|
Invention
|
Novel compound having angiogenesis inhibitory activity, method for preparing same, and pharmaceut... |
|
|
Invention
|
Combined formulation with improved stability.
Disclosed is a combined formulation for oral admin... |
|
2011
|
Invention
|
Pre-freeze dried azacitidine preparation, freeze dried azacitidine preparation and method of manu... |
|
|
Invention
|
Antihypertensive pharmaceutical composition. Provided is an antihypertensive pharmaceutical compo... |
|
2010
|
G/S
|
Capsules for medicines, namely capsules sold empty, capsules containing antihypertensives; Chemic... |
|
2009
|
G/S
|
Pharmaceutical preparations. |
